Jason E. Morrow is a litigation associate in the Washington, D.C. office of Gibson, Dunn & Crutcher, and focuses on securities litigation and white collar criminal defense. Mr. Morrow has represented numerous public companies, their directors, and their executives in securities and derivative litigation at the federal and state level. Mr. Morrow has also represented clients in criminal and regulatory enforcement proceedings brought by the Department of Justice, the SEC, the Food and Drug Administration, and other federal and state agencies. He has advised directors and board committees on shareholder litigation, government investigations, and corporate governance issues.
Representative Matters

K-V Pharmaceutical Company: Representing K-V Pharmaceutical and its officers in securities class action and derivative litigation in Missouri state and federal courts. The claims arise out of stock price declines following the FDA’s decision not to enforce K-V’s statutory exclusivity over a new drug. Mr. Morrow argued the motion to dismiss the class action; a decision is pending.
Duke Energy: Representing the Duke Energy legacy members of the board of directors in securities class action and derivative litigation; the cases are at the pleadings stage. Represented the same directors in a resolved regulatory matter arising from the corporate merger of Duke and Progress Energy.
Chevron Corporation: Representing Chevron Corporation in its racketeering action against New York lawyer Steven Donziger and others responsible for a fraudulent $9 billion judgment against Chevron. Following a six-week trial, the trial court found that Chevron had proved that defendants had violated RICO and had procured the Ecuadorian judgment by fraud. The court enjoined Donziger and others from profiting from that judgment.
K-V Pharmaceutical Company: Represented K-V in investigation by Department of Justice and the FDA’s Office of Criminal Investigations into alleged distribution of pharmaceutical products that were not in compliance with current Good Manufacturing Practices. Investigation was resolved with plea agreement that allowed K-V to remain in business. Defended K-V and its CEO in securities and derivative litigation arising out of the same events. Secured dismissal of derivative action. Settlement of the securities class action is pending court approval.
King Pharmaceuticals: Represented King and its officers and directors in securities class action and derivative litigation stemming from government investigation into the Company’s underpayment of Medicaid rebates. Cases were successfully resolved on favorable terms.
Integral Systems: Represented Integral and its officers and directors in securities class action and derivative litigation following merger announcement. Negotiated settlement of litigation via supplemental disclosures to shareholders, which allowed the merger to close.
Maryland State Conference of NAACP Branches: Represented NAACP and fourteen individual plaintiffs in high profile impact litigation against the Baltimore City Police Department, alleging pattern of arrests for quality of life offenses without probable cause. Negotiated settlement requiring changes to BPD policies, additional officer training, data tracking, appointment of a compliance auditor, and damages. Received Gibson Dunn’s annual Frank Wheat Award in 2010 for pro bono work.

Mr. Morrow received his law degree in 2005 from the New York University School of Law, where he was an Articles Editor of the Annual Survey of American Law. He graduated from Duke University in 2001 with a degree in political science. Mr. Morrow is a member of the District of Columbia bar.